Home | Business News | Browse by Publication | H | Harvard Health Letter

Hormone therapy: The risk-benefit tightrope.

Publication: Harvard Health Letter
Publication Date: 01-JUL-07 		Format: Online
Delivery: Immediate Online Access
Full Article Title: Hormone therapy: The risk-benefit tightrope.(Women's Health Initiative)

Article Excerpt
Women must balance heart disease protection and breast cancer risk.

It was a shock several years ago when results from a large, government-funded study called the Women's Health Initiative (WHI) showed that postmenopausal women who took hormones were more likely to have heart problems than those who didn't. Previous research had pointed to both risks and benefits from hormone therapy. The risks? Stroke, blood clots in the veins that could potentially travel to the lungs (pulmonary emboli), and most of all, breast cancer -- all were more likely with hormone therapy.

But on the benefit side of the equation were a lower risk for colon cancer, protection against broken bones, relief from a variety of postmenopausal symptoms like hot flashes and night sweats -- and protection against heart disease. And since heart disease is by far the most common cause of both death and disability in women, protection against heart disease was important.

But the 2002 WHI results threw the risk-benefit balancing act out of alignment. It seemed that hormone therapy increased the risk for both the most feared disease, breast cancer, and...

Read the FULL article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 3 Days!
Tell Me More   Terms and Conditions

Get Goliath Business News for 1 year - Just $99 (Save 65%)
Tell Me More   Terms and Conditions

Already a subscriber? Log in to view full article



More articles from Harvard Health Letter
Duct tape, warts and all., July 01, 2007
An update on the "old man's friend".(pneumonia), July 01, 2007
More on niacin: No flush, no good., July 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.